Cite
Long term outcome after 48 Gy stereotactic ablative body radiotherapy for peripheral stage I non-small cell lung cancer.
MLA
Dubaere, Emilie, et al. “Long Term Outcome after 48 Gy Stereotactic Ablative Body Radiotherapy for Peripheral Stage I Non-Small Cell Lung Cancer.” BMC Cancer, vol. 19, no. 1, June 2019, p. 639. EBSCOhost, https://doi.org/10.1186/s12885-019-5863-2.
APA
Dubaere, E., Goffaux, M., Wanet, M., Bihin, B., Gheldof, C., Demoulin, A.-S., Bolly, A., Bustin, F., Duplaquet, F., Baugnee, P.-E., Gustin, M., Hers, V., Maisin, F., Marchand, E., Ocak, S., Pirard, L., Vancutsem, O., Van Neck, E., Vandermoten, G., … Remouchamps, V. (2019). Long term outcome after 48 Gy stereotactic ablative body radiotherapy for peripheral stage I non-small cell lung cancer. BMC Cancer, 19(1), 639. https://doi.org/10.1186/s12885-019-5863-2
Chicago
Dubaere, Emilie, Mathilde Goffaux, Marie Wanet, Benoit Bihin, Céline Gheldof, Anne-Sophie Demoulin, Antoine Bolly, et al. 2019. “Long Term Outcome after 48 Gy Stereotactic Ablative Body Radiotherapy for Peripheral Stage I Non-Small Cell Lung Cancer.” BMC Cancer 19 (1): 639. doi:10.1186/s12885-019-5863-2.